[HTML][HTML] The effect of pathophysiology on pharmacokinetics in the critically ill patient—concepts appraised by the example of antimicrobial agents

SI Blot, F Pea, J Lipman - Advanced drug delivery reviews, 2014 - Elsevier
Critically ill patients are at high risk for development of life-threatening infection leading to
sepsis and multiple organ failure. Adequate antimicrobial therapy is pivotal for optimizing the …

Clinical implications of antibiotic pharmacokinetic principles in the critically ill

AA Udy, JA Roberts, J Lipman - Intensive care medicine, 2013 - Springer
Successful antibiotic therapy in the critically ill requires sufficient drug concentrations at the
site of infection that kill or suppress bacterial growth. The relationship between antibiotic …

Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American …

MJ Rybak, J Le, TP Lodise, DP Levine… - American Journal of …, 2020 - academic.oup.com
Methods These are the consensus statements and guideline of ASHP, IDSA, the Pediatric
Infectious Diseases Society (PIDS), and SIDP. Guideline panel composition consisted of …

How do we use therapeutic drug monitoring to improve outcomes from severe infections in critically ill patients?

G Wong, FB Sime, J Lipman, JA Roberts - BMC infectious diseases, 2014 - Springer
High mortality and morbidity rates associated with severe infections in the critically ill
continue to be a significant issue for the healthcare system. In view of the diverse and …

Pharmacokinetic/pharmacodynamic considerations for the optimization of antimicrobial delivery in the critically ill

D Tsai, J Lipman, JA Roberts - Current opinion in critical care, 2015 - journals.lww.com
Optimization of antimicrobial dosing in accordance with pharmacokinetics/
pharmacodynamics targets can improve survival and clinical cure. Dosing regimens for …

Does contemporary vancomycin dosing achieve therapeutic targets in a heterogeneous clinical cohort of critically ill patients? Data from the multinational DALI study

S Blot, D Koulenti, M Akova, M Bassetti, JJ De Waele… - Critical Care, 2014 - Springer
Introduction The objective of this study was to describe the pharmacokinetics of vancomycin
in ICU patients and to examine whether contemporary antibiotic dosing results in …

Epidemiology of augmented renal clearance in mixed ICU patients

J De Waele, A Dumoulin, A Janssen… - Minerva …, 2015 - biblio.ugent.be
Background. Augmented renal clearance (ARC) or renal hyperfiltration is increasingly
reported in intensive care unit (ICU) patients. The goal of this analysis was to study the …

New regimen for continuous infusion of vancomycin in critically ill patients

S Cristallini, M Hites, H Kabtouri… - Antimicrobial agents …, 2016 - Am Soc Microbiol
Despite the development of new agents with activity against Gram-positive bacteria,
vancomycin remains one of the primary antibiotics for critically ill septic patients. Because …

Decreasing the time to achieve therapeutic vancomycin concentrations in critically ill patients: developing and testing of a dosing nomogram

JP Baptista, JA Roberts, E Sousa, R Freitas, N Deveza… - Critical Care, 2014 - Springer
Introduction Achievement of optimal vancomycin exposure is crucial to improve the
management of patients with life-threatening infections caused by susceptible Gram-positive …

The influence of acute kidney injury on antimicrobial dosing in critically ill patients: are dose reductions always necessary?

S Blot, J Lipman, DM Roberts, JA Roberts - Diagnostic microbiology and …, 2014 - Elsevier
Optimal dosing of antimicrobial therapy is pivotal to increase the likelihood of survival in
critically ill patients with sepsis. Drug exposure that maximizes bacterial killing, minimizes …